Skip to main content
Clinical Trials/NCT07230782
NCT07230782CompletedNot Applicable

Percutaneous Ultrasound-Guided Release of the Transverse Carpal Ligament Versus Open Surgery for Carpal Tunnel Syndrome: A Prospective Comparative Study

Fundacin Biomedica Galicia Sur1 site in 1 country200 target enrollmentStarted: January 10, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
200
Locations
1
Primary Endpoint
Functional outcome measured by the Boston Carpal Tunnel Questionnaire

Study Overview

Brief Summary

The goal of this clinical trial is to compare the clinical and functional outcomes of two surgical approaches for the treatment of carpal tunnel syndrome (CTS): ultrasound-guided percutaneous release of the flexor retinaculum and conventional open surgery. The study population includes adults diagnosed with carpal tunnel syndrome who are candidates for surgical treatment.

The main questions this study aims to answer are:

Does ultrasound-guided percutaneous flexor retinaculum release provide superior short-term functional outcomes compared with conventional open surgery?

Does the minimally invasive approach lead to faster symptom relief and postoperative recovery?

Researchers will compare the percutaneous ultrasound-guided technique with the traditional open palmar incision to determine whether the minimally invasive method offers measurable clinical advantages.

Participants will:

Undergo either ultrasound-guided percutaneous release or standard open surgical release, depending on group allocation.

Complete validated clinical and functional assessments at predefined postoperative time points.

Report symptom severity, functional status, and any procedure-related adverse events.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults aged 18 years or older
  • •Residence within the hospital's health area
  • •Clinical and neurophysiological diagnosis of carpal tunnel syndrome
  • •Underwent surgical treatment between January 2021 and January 2024
  • •Provided written informed consent for participation and for the publication of anonymized data

Exclusion Criteria

  • •Previous surgery for the same pathology in the same hand
  • •Presence of another associated hand pathology in the same hand
  • •Patients unable or incapacitated to follow the study protocol

Arms & Interventions

Percutaneous Ultrasound Guided Release

Experimental

Intervention: Percutaneous Ultrasound Guided Release of the Transverse Carpal Ligament (Procedure)

Open surgery

Active Comparator

Intervention: Open release surgery (Procedure)

Outcomes

Primary Outcomes

Functional outcome measured by the Boston Carpal Tunnel Questionnaire

Time Frame: 3 and 12 months

The Boston Carpal Tunnel Questionnaire - Symptom Severity Scale and Functional Status Scale, each scored from 1 (no symptoms / no difficulty) to 5 (severe symptoms / inability to perform activities), where higher scores indicate worse clinical symptoms and greater functional impairment.

Secondary Outcomes

  • Rate of procedure-related adverse events(Intraoperative and up to 12 months postoperative)
  • Pain intensity measured using the Visual Analog Scale(3 and 12 months)
  • Grip strength measured with a calibrated dynamometer(3 and 12 months)
  • Time to return to normal daily activities(Up to 12 months)
  • Scar-related symptoms and satisfaction(3 and 12 months)

Investigators

Sponsor
Fundacin Biomedica Galicia Sur
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Diego Matías Domínguez Prado

Principal Investigator. Attending phsysician. Orthopaedic Surgeon.

Fundacin Biomedica Galicia Sur

Study Sites (1)

Loading locations...

Similar Trials